Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Maxcyte, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 114 | 1 | 120 | +7 |
| Shares | 68.3M | 8.14M | 68.7M | +8.54M (+14.2%) |
| Value | $268.0M | $31.9M | $267.4M | +$31.3M (+13.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Maxcyte, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 8,488,107 | $33.0M | 0.00% |
| CenterBook Partners LP | 585,086 | $2.28M | 0.14% |
| Franklin Resources Inc | 67,249 | $260.3K | 0.00% |
| AJOVista, LLC | 38,707 | $150.6K | 0.64% |
| Sherbrooke Park Advisers LLC | 35,287 | $137.3K | 0.03% |
| D. E. Shaw & Co., Inc. | 24,496 | $95.3K | 0.00% |
| Intech Investment Management LLC | 13,114 | $51.0K | 0.00% |
| State of Wyoming | 12,413 | $48.3K | 0.01% |
| Prelude Capital Management, LLC | 10,700 | $41.6K | 0.00% |
| Sterling Capital Management LLC | 367 | $1.43K | 0.00% |
| Bessemer Group Inc | 300 | $1.00K | 0.00% |
| Smartleaf Asset Management LLC | 172 | $665 | 0.00% |
| Capital Performance Advisors LLP | 12 | $47 | 0.00% |
Sold out (6)
Institutions that held Maxcyte, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Blue Water Life Science Advisors, LLC | 603,937 | $2.37M |
| Massachusetts Financial Services Co | 499,635 | $1.96M |
| Two Sigma Investments, LP | 23,406 | $91.8K |
| Grandeur Peak Global Advisors, LLC | 16,588 | $65.0K |
| Principal Financial Group Inc | 14,724 | $57.7K |
| Advisor Group Holdings, Inc. | 125 | $490 |
Not filed for Q3 2024 yet (1)
Institutions that held Maxcyte, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 8,142,364 | $31.9M |